Cardinal Health Q2 EPS Estimate Raised by Leerink Partnrs

Cardinal Health, Inc. (NYSE:CAH) – Leerink Partnrs lifted their Q2 2026 EPS estimates for Cardinal Health in a research note issued to investors on Thursday, October 30th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $2.25 for the quarter, up from their prior forecast of $2.24. The consensus estimate for Cardinal Health’s current full-year earnings is $7.95 per share. Leerink Partnrs also issued estimates for Cardinal Health’s Q3 2026 earnings at $2.74 EPS, Q4 2026 earnings at $2.29 EPS, FY2026 earnings at $9.84 EPS, FY2027 earnings at $11.08 EPS, FY2028 earnings at $12.42 EPS and FY2029 earnings at $14.00 EPS.

Several other equities analysts also recently commented on the stock. UBS Group boosted their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research note on Friday. Citigroup boosted their price target on shares of Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. TD Cowen boosted their price target on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday. Evercore ISI boosted their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Finally, Mizuho boosted their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the stock an “outperform” rating in a research note on Monday. Eleven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $200.54.

Cardinal Health Stock Performance

NYSE CAH opened at $195.30 on Monday. The firm has a 50 day simple moving average of $157.00 and a 200-day simple moving average of $155.47. Cardinal Health has a one year low of $110.63 and a one year high of $197.67. The firm has a market cap of $46.40 billion, a price-to-earnings ratio of 30.28, a PEG ratio of 1.39 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. During the same period last year, the business earned $1.88 earnings per share. The business’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were paid a $0.5107 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s payout ratio is currently 30.77%.

Insider Buying and Selling

In other news, CEO Jason M. Hollar sold 107,705 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total transaction of $16,037,274.50. Following the completion of the sale, the chief executive officer owned 235,901 shares in the company, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jessica L. Mayer sold 38,078 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the sale, the insider owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 271,676 shares of company stock valued at $40,489,525 over the last ninety days. 0.12% of the stock is currently owned by corporate insiders.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC raised its position in Cardinal Health by 3.3% in the 2nd quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock valued at $1,069,005,000 after purchasing an additional 205,539 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares during the period. Norges Bank acquired a new position in Cardinal Health in the 2nd quarter valued at $584,420,000. Northern Trust Corp increased its stake in Cardinal Health by 3.5% in the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company’s stock valued at $433,012,000 after buying an additional 105,154 shares during the period. Finally, Invesco Ltd. increased its stake in Cardinal Health by 7.3% in the 2nd quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after buying an additional 207,750 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.